Cyber & Technology March 30, 2026 112 stories in this edition

Hong Kong-listed Insilico Medicine signs AI drug development deal with Eli Lilly

SCMP Asia / Asia / 1m ago / Julie Zhang
Hong Kong-listed Insilico Medicine signs AI drug development deal with Eli Lilly

Preview Brief

Insilico Medicine has signed a potential multibillion-dollar deal with Eli Lilly to license out an early-stage drug pipeline and provide its artificial intelligence platform services in research and development collaborations. Under the agreement announced on Monday, US-headquartered, Hong Kong-listed Insilico will receive an upfront payment of US$115 million. The deal could have a total value of around US$2.75 billi...

Feed Summary

Insilico Medicine has signed a potential multibillion-dollar deal with Eli Lilly to license out an early-stage drug pipeline and provide its artificial intelligence platform services in research and development collabora...

Related In Edition

More from Cyber & Technology

Related previews keep the same media frame and preserve your current desk context so you can continue scanning without losing the edition flow.